Physician profile
Kendall Griffith
NPI 1710968060
$21,300.45
in general payments reported to CMS, 2019-2025
34 companies · $2,470 in 2025
The $2,470 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,444 · 2020: $308 · 2021: $421 · 2022: $3,471 · 2023: $8,684 · 2024: $3,502 · 2025: $2,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,851 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,550 · Travel and Lodging: $4,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,851.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,550.00 |
| Travel and Lodging | $4,254.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,186.96 | 2022-2024 | Venaseal, Micra, Symplicity G3 |
| Abbott Laboratories | $1,503.94 | 2023-2025 | Supera, Aveir, Assurity |
| Cardiovascular Systems INC. | $1,314.14 | 2019-2022 | |
| Medtronic Vascular, INC. | $909.92 | 2019 | |
| Boston Scientific Corporation | $878.26 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Varithena Administration Pack, Latitude Communicator Power Supply |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $763.34 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $720.43 | 2020-2024 | Farxiga, Andexxa, Brilinta |
| Novartis Pharmaceuticals Corporation | $539.41 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $491.83 | 2021-2025 | Verquvo, Capvaxive |
| Abiomed | $418.98 | 2023-2024 | Impella |
| Shockwave Medical, INC | $353.13 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Atricure, INC. | $341.27 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $288.92 | 2021-2025 | Jardiance |
| Cvrx, INC. | $265.17 | 2023-2025 | Barostim Neo System |
| Philips North America LLC | $265.12 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, Ecc Solutions, Extended Holter |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $212.22 | 2023-2024 | Inpefa |
| Inari Medical, INC. | $131.68 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Baxter Healthcare | $104.45 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $80.27 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $64.85 | 2021-2024 | Xarelto |
| Vital Connect, INC | $55.22 | 2023-2025 | Vitalpatch Rtm |
| Actelion Pharmaceuticals US, INC. | $52.54 | 2022 | |
| Pfizer INC. | $46.71 | 2019-2023 | |
| Amgen INC. | $40.92 | 2019-2024 | Repatha |
| Exact Sciences Corporation | $35.36 | 2025 | The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $34.07 | 2021-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $32.91 | 2025 | |
| Inspire Medical Systems, INC. | $32.27 | 2025 | Inspire |
| Acist Medical Systems, INC. | $29.72 | 2025 | |
| Amarin Pharma, INC. | $26.24 | 2021 | |
| Stryker Corporation | $23.01 | 2025 | Flowtriever |
| Medicomp INC | $20.72 | 2023 | Telepatch Cardiac Monitor |
| Alnylam Pharmaceuticals INC. | $20.69 | 2025 | Amvuttra |
| Cleerly, INC. | $15.78 | 2025 | Cleerly Ischemia, Cleerly Labs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendall Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.